HealthQuest Capital, Lily Asia Ventures, OrbiMed Advisors and InterWest Partners invested $25M into Avedro, an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling.   The funding will be used to invest in product development, clinical studies and commercial efforts, including expansion of sales and reimbursement support.